Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.595 USD | +0.06% | -2.67% | -13.24% |
Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.24% | 2.04B | |
+2.69% | 108B | |
+10.14% | 105B | |
+1.57% | 23.46B | |
-12.16% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.93% | 17.19B | |
+6.16% | 13.99B | |
+36.32% | 12.53B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- TD Cowen Starts Recursion Pharmaceuticals With Market Perform Rating